trending Market Intelligence /marketintelligence/en/news-insights/trending/BXqZqVaemKYILDb5yXimzQ2 content esgSubNav
In This List

Sofinnova Partners closes VC fund at €333M

Blog

Banking Essentials Newsletter: July Edition - Part 2

Blog

Anticipate the Unknown Go Beyond Fundamentals to Uncover Early Signs of Private Company Credit Deterioration

Blog

Taking Loss Given Default Estimation to the Next Level: An Aspiration for All Creditors, Not Just Banks

Blog

Anticipate the Unknown A Fundamentals Approach to Detect Early Signs of Private Company Credit Deterioration


Sofinnova Partners closes VC fund at €333M

Sofinnova Partners raised €333 million for its latest healthcare venture capital fund.

Sofinnova Capital IX will target the biopharmaceutical and medical device sectors. Two-thirds of the investments will be placed in European companies and a third in companies outside of Europe, primarily in North America.

Triago acted as placement agent, while Clifford Chance was the legal counsel.

Sofinnova Partners specializes in life sciences and makes investments across development stages.